Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia
Giselli Scaini(The University of Texas MD Anderson Cancer Center), Consuelo Walss‐Bass(The University of Texas Health Science Center at Houston), Henriette Raventós(Universidad de Costa Rica), João Quevedo(The University of Texas Health Science Center), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), David L. Roberts(The University of Texas at San Antonio Health Science Center)
Cited by 64
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325